EcoDrugPlus

Natriuretic Peptide Receptor 2

Ensembl ID : ENSDLEG00000015834
Gene Symbol: NPR2
3 Cross references
260 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSDLEG00000013656
Gene Symbol: NPR3
3 Cross references
210 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSDLEG00000013166
Gene Symbol: NPY2R
1 Cross references
248 Possible Orthologues:

Neuropeptide Y Receptor Y4-2

Ensembl ID : ENSDLEG00000011723
Gene Symbol: NPY4R2
3 Cross references
116 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSDLEG00000004085
Gene Symbol: NPY5R
3 Cross references
137 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSDLEG00000006619
Gene Symbol: NTSR1
3 Cross references
208 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSDLEG00000008045
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSDLEG00000012748
Gene Symbol: NTRK2
3 Cross references
288 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSDLEG00000006137
Gene Symbol: NTRK3
3 Cross references
271 Possible Orthologues:

Nicastrin

Ensembl ID : ENSDLEG00000013787
Gene Symbol: NCSTN
3 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSDLEG00000000938
Gene Symbol: NAMPT
3 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSDLEG00000021546
Gene Symbol: NISCH
3 Cross references
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).